Literature DB >> 8988166

Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome.

T D Howard1, W A Paznekas, E D Green, L C Chiang, N Ma, R I Ortiz de Luna, C Garcia Delgado, M Gonzalez-Ramos, A D Kline, E W Jabs.   

Abstract

Saethre-Chotzen syndrome is one of the most common autosomal dominant disorders of craniosynostosis in humans and is characterized by craniofacial and limb anomalies. The locus for Saethre-Chotzen syndrome maps to chromosome 7p21-p22. We have evaluated TWIST, a basic helix-loop-helix transcription factor, as a candidate gene for this condition because its expression pattern and mutant phenotypes in Drosophila and mouse are consistent with the Saethre-Chotzen phenotype. We mapped TWIST to human chromosome 7p21-p22 and mutational analysis reveals nonsense, missense, insertion and deletion mutations in patients. These mutations occur within the basic DNA binding, helix I and loop domains, or result in premature termination of the protein. Studies in Drosophila indicate that twist may affect the transcription of fibroblast growth factor receptors (FGFRs), another gene family implicated in human craniosynostosis. The emerging cascade of molecular components involved in craniofacial and limb development now includes TWIST, which may function as an upstream regulator of FGFRs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988166     DOI: 10.1038/ng0197-36

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  165 in total

Review 1.  Derivation of the mammalian skull vault.

Authors:  G M Morriss-Kay
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

2.  A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development.

Authors:  E W Jabs
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 3.  The sonic hedgehog-patched-gli pathway in human development and disease.

Authors:  E H Villavicencio; D O Walterhouse; P M Iannaccone
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

4.  Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.

Authors:  W Reardon; D Wilkes; P Rutland; L J Pulleyn; S Malcolm; J C Dean; R D Evans; B M Jones; R Hayward; C M Hall; N C Nevin; M Baraister; R M Winter
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

5.  Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening.

Authors:  Juanliang Cai; Barbara K Goodman; Ankita S Patel; John B Mulliken; Lionel Van Maldergem; George E Hoganson; William A Paznekas; Ziva Ben-Neriah; Ruth Sheffer; Michael L Cunningham; Donna L Daentl; Ethylin Wang Jabs
Journal:  Hum Genet       Date:  2003-09-25       Impact factor: 4.132

6.  Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells.

Authors:  Hai-Yun Yen; Man-Chun Ting; Robert E Maxson
Journal:  Dev Biol       Date:  2010-08-19       Impact factor: 3.582

Review 7.  Molecular genetics of craniosynostotic syndromes.

Authors:  U Müller; D Steinberger; S Kunze
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

8.  Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning.

Authors:  B D Harfe; A Vaz Gomes; C Kenyon; J Liu; M Krause; A Fire
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

Review 9.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 10.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.